BioMarin Announces Strong Second Quarter 2023 Results and Record Breaking Revenues for the First Half of 2023, Including 13% Year Over Year Growth Year-to-date
Go back to BioMarin Announces Strong Second Quarter 2023 Results and Record Breaking Revenues for the First Half of 2023, Including 13% Year Over Year Growth Year-to-date| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 66.53 +0.10 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.43 | 52 Week High | $108.96 | |||
| Open | $65.79 | 52 Week Low | $62.12 | |||
| Day High | $66.64 | P/E | N/A | |||
| Day Low | $65.52 | EPS | $-1.27 | |||
| Volume | 2,299,209 | |||||
